Balance Sheet NEXON Co., Ltd.

Equities

3659

JP3758190007

Internet Services

Market Closed - Japan Exchange Other stock markets 11:30:00 06/09/2024 am IST			5-day change	1st Jan Change
2,730.00 ^JPY	-2.85%		-4.55%	+6.25%

04/09	Nexon Targets 750 Billion Yen in Sales by 2027	MT
19/08	Jefferies Adjusts Nexon's Price Target to 4,870 Yen From 4,340 Yen, Keeps at Buy	MT

c1dcb141f0b06a5c.b4dXqOBbcKyMPjc4ABv6I7l7ojGS-B17X_dp8EuzWdE.GrFv-LcoL9n8WmV5MkKKeo0P0n__iU8PMpMOtSzkLpUf1zLqhTA42b9Wbg

Published financial data: NEXON CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	25TCr	29TCr	27TCr	35TCr	42TCr
Total Revenues	25TCr	29TCr	27TCr	35TCr	42TCr
Cost of Goods Sold, Total	5.96TCr	6.9TCr	7.21TCr	11TCr	14TCr
Gross Profit	19TCr	22TCr	20TCr	25TCr	29TCr
Selling General & Admin Expenses, Total	6.63TCr	8.19TCr	8.2TCr	11TCr	12TCr
Provision for Bad Debts	-	-	-	-	558.9Cr
R&D Expenses	1.49TCr	1.65TCr	2.1TCr	2.59TCr	2.46TCr
Depreciation & Amortization - (IS)	396.8Cr	525.2Cr	544.4Cr	374.7Cr	430.7Cr
Other Operating Expenses	-126.3Cr	-119.2Cr	-44Cr	-43Cr	-11Cr
Other Operating Expenses, Total	8.39TCr	10TCr	11TCr	14TCr	15TCr
Operating Income	11TCr	12TCr	9.43TCr	11TCr	13TCr
Interest Expense, Total	-40Cr	-36Cr	-42Cr	-59Cr	-141Cr
Interest And Investment Income	1.34TCr	827.5Cr	645.2Cr	1.3TCr	2.46TCr
Net Interest Expenses	1.3TCr	791.8Cr	603.7Cr	1.24TCr	2.32TCr
Income (Loss) On Equity Invest.	-32Cr	76Cr	-100Cr	-1.02TCr	-351Cr
Currency Exchange Gains (Loss)	1.62TCr	-1.77TCr	3.64TCr	4.17TCr	1.04TCr
Other Non Operating Income (Expenses)	-18Cr	-19Cr	-39Cr	66Cr	9.5Cr
EBT, Excl. Unusual Items	13TCr	11TCr	14TCr	15TCr	16TCr
Gain (Loss) On Sale Of Investments	610.6Cr	125.4Cr	393.5Cr	-233.1Cr	211.6Cr
Gain (Loss) On Sale Of Assets	-4.3Cr	-5.6Cr	-50L	-3.2Cr	-80L
Asset Writedown	-1.79TCr	-527.3Cr	-382.7Cr	-1.07TCr	-3.86TCr
EBT, Incl. Unusual Items	12TCr	11TCr	14TCr	14TCr	13TCr
Income Tax Expense	873.2Cr	5.27TCr	2.24TCr	4.05TCr	5.48TCr
Earnings From Continuing Operations	11TCr	5.55TCr	11TCr	10TCr	7.11TCr
Net Income to Company	11TCr	5.55TCr	11TCr	10TCr	7.11TCr
Minority Interest	242.8Cr	73Cr	182.2Cr	35Cr	-48Cr
Net Income - (IS)	12TCr	5.62TCr	11TCr	10TCr	7.06TCr
Net Income to Common Incl Extra Items	12TCr	5.62TCr	11TCr	10TCr	7.06TCr
Net Income to Common Excl. Extra Items	12TCr	5.62TCr	11TCr	10TCr	7.06TCr
Per Share Items
Net EPS - Basic	129.34	63.57	128.91	114.74	82.89
Basic EPS - Continuing Operations	129.34	63.57	128.91	114.74	82.89
Basic Weighted Average Shares Outstanding	89Cr	88Cr	89Cr	87Cr	85Cr
Net EPS - Diluted	128.03	61.9	126.55	113.81	82.33
Diluted EPS - Continuing Operations	128.03	61.9	126.55	113.81	82.33
Diluted Weighted Average Shares Outstanding	90Cr	89Cr	90Cr	88Cr	86Cr
Normalized Basic EPS	96.23	80.16	96.98	110.16	118.62
Normalized Diluted EPS	95.5	79.3	95.74	109.27	117.84
Dividend Per Share	2.5	5	7.5	10	10
Payout Ratio	-	7.86	3.87	8.76	12.15
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	11TCr	13TCr	10TCr	12TCr	14TCr
EBITA	11TCr	12TCr	9.43TCr	11TCr	13TCr
EBIT	11TCr	12TCr	9.43TCr	11TCr	13TCr
Effective Tax Rate - (Ratio)	7.16	48.7	16.54	28.85	43.55
Normalized Net Income	8.61TCr	7.09TCr	8.64TCr	9.63TCr	10TCr
Supplemental Operating Expense Items
Advertising Expense	1.87TCr	2.04TCr	1.74TCr	2.57TCr	3.3TCr
Selling and Marketing Expenses	2.4TCr	2.7TCr	2.31TCr	3.28TCr	4.35TCr
General and Administrative Expenses	153.8Cr	185.4Cr	283.9Cr	448.3Cr	341.5Cr
Research And Development Expense From Footnotes	1.49TCr	1.65TCr	2.1TCr	2.59TCr	2.46TCr

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	25TCr	25TCr	37TCr	41TCr	28TCr
Short Term Investments	26TCr	27TCr	17TCr	16TCr	32TCr
Total Cash And Short Term Investments	51TCr	53TCr	53TCr	57TCr	60TCr
Accounts Receivable, Total	2.86TCr	2.09TCr	1.76TCr	3.04TCr	3.79TCr
Total Receivables	2.86TCr	2.09TCr	1.76TCr	3.04TCr	3.79TCr
Other Current Assets, Total	1.39TCr	3.19TCr	4.12TCr	3.97TCr	5.49TCr
Total Current Assets	55TCr	58TCr	59TCr	64TCr	69TCr
Net Property Plant And Equipment	3.01TCr	3.42TCr	3.54TCr	4.6TCr	5.29TCr
Long-term Investments	5TCr	17TCr	26TCr	25TCr	24TCr
Goodwill	4.25TCr	3.84TCr	3.89TCr	4.01TCr	4.39TCr
Other Intangibles, Total	2.15TCr	1.49TCr	1.77TCr	965.5Cr	1.78TCr
Deferred Tax Assets Long-Term	2.15TCr	2.2TCr	3.82TCr	5.71TCr	5.59TCr
Total Assets	72TCr	86TCr	99TCr	1,04300Cr	1,09800Cr
Liabilities
Accounts Payable, Total	775.3Cr	1.07TCr	935.4Cr	1.47TCr	1.63TCr
Accrued Expenses, Total	406.8Cr	687.5Cr	578.7Cr	1.02TCr	1.17TCr
Short-term Borrowings	222.3Cr	209.4Cr	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	212.9Cr	265.7Cr	304.5Cr	404.5Cr	563.4Cr
Current Income Taxes Payable	740.3Cr	1.58TCr	1.66TCr	2.37TCr	1.79TCr
Unearned Revenue Current, Total	1.02TCr	1.15TCr	1.1TCr	1.89TCr	2.11TCr
Other Current Liabilities	734.2Cr	839.4Cr	751Cr	1.16TCr	1.67TCr
Total Current Liabilities	4.12TCr	5.8TCr	5.33TCr	8.31TCr	8.94TCr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	850.7Cr	1.18TCr	1.23TCr	1.93TCr	2.41TCr
Deferred Tax Liability Non Current	1.68TCr	5.11TCr	5.4TCr	5.04TCr	5.17TCr
Other Non Current Liabilities	2.15TCr	2.08TCr	2.12TCr	2.25TCr	2.63TCr
Total Liabilities	8.8TCr	14TCr	14TCr	18TCr	19TCr
Common Stock, Total	1.8TCr	2.27TCr	3.43TCr	3.9TCr	4.75TCr
Additional Paid In Capital	3.57TCr	1.74TCr	1.5TCr	1.83TCr	2.67TCr
Retained Earnings	56TCr	60TCr	71TCr	70TCr	71TCr
Treasury Stock	-2.72TCr	-	-1.79TCr	-1.65TCr	-4.5TCr
Comprehensive Income and Other	3.85TCr	7TCr	9.27TCr	11TCr	16TCr
Total Common Equity	62TCr	71TCr	84TCr	86TCr	90TCr
Minority Interest	1.11TCr	1.06TCr	922.5Cr	935.3Cr	1.03TCr
Total Equity	63TCr	72TCr	85TCr	87TCr	91TCr
Total Liabilities And Equity	72TCr	86TCr	99TCr	1,04300Cr	1,09800Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	88Cr	89Cr	89Cr	86Cr	84Cr
ECS Total Common Shares Outstanding	88Cr	89Cr	89Cr	86Cr	84Cr
Book Value / Share	702.6	800.35	939.19	996.95	1.06T
Tangible Book Value	56TCr	66TCr	78TCr	81TCr	83TCr
Tangible Book Value Per Share	630.07	740.19	875.61	939.11	991.51
Total Debt	1.29TCr	1.66TCr	1.53TCr	2.33TCr	2.97TCr
Net Debt	-50TCr	-51TCr	-52TCr	-55TCr	-57TCr
Minority Interest, Total (Incl. Fin. Div)	1.11TCr	1.06TCr	922.5Cr	935.3Cr	1.03TCr
Equity Method Investments, Total	251.5Cr	519.5Cr	5.89TCr	8.36TCr	5.81TCr
Full Time Employees	6.43T	6.29T	6.68T	7.47T	8.23T
Accumulated Allowance for Doubtful Accounts (Supple)	106.6Cr	107.6Cr	106.5Cr	98Cr	87Cr

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	12TCr	11TCr	14TCr	14TCr	13TCr
Depreciation & Amortization - CF	769.4Cr	857.4Cr	846.8Cr	676.7Cr	859.8Cr
Depreciation & Amortization, Total	769.4Cr	857.4Cr	846.8Cr	676.7Cr	859.8Cr
(Gain) Loss From Sale Of Asset	1.8TCr	965.5Cr	294.1Cr	533.7Cr	304Cr
(Gain) Loss on Sale of Investments - (CF)	-	-438.2Cr	-70Cr	102.5Cr	3.97TCr
(Income) Loss On Equity Investments - (CF)	32Cr	-76Cr	100Cr	1.02TCr	351Cr
Other Operating Activities, Total	-2.19TCr	-1.48TCr	-3.65TCr	-4.02TCr	-5.78TCr
Change In Accounts Receivable	-30Cr	585.5Cr	481.6Cr	-896.8Cr	-451.6Cr
Change In Accounts Payable	45Cr	269.1Cr	-146.6Cr	408.9Cr	95Cr
Change in Other Net Operating Assets	-2.11TCr	2.27TCr	-815.9Cr	1.13TCr	934.1Cr
Cash from Operations	11TCr	14TCr	11TCr	13TCr	13TCr
Capital Expenditure	-142.5Cr	-234.2Cr	-158.5Cr	-280.1Cr	-340.7Cr
Sale of Property, Plant, and Equipment	15Cr	7.7Cr	6.8Cr	12Cr	4.1Cr
Cash Acquisitions	-686.4Cr	-207.5Cr	-5.26TCr	-2.9TCr	-2.66TCr
Divestitures	28Cr	5.5Cr	-	961Cr	13Cr
Sale (Purchase) of Intangible assets	-69Cr	-89Cr	-1.25TCr	-310.1Cr	-230.6Cr
Investment in Marketable and Equity Securities, Total	-1.92TCr	-13TCr	8.91TCr	2.15TCr	-15TCr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-1Cr	-426.7Cr	-613Cr
Other Investing Activities, Total	-91Cr	-204.3Cr	-427.5Cr	-296.6Cr	-129.6Cr
Cash from Investing	-2.86TCr	-14TCr	1.81TCr	-1.09TCr	-19TCr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-185.2Cr	-14Cr	-209.4Cr	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-185.2Cr	-14Cr	-209.4Cr	-	-
Issuance of Common Stock	312.7Cr	705Cr	410.1Cr	602.3Cr	1.25TCr
Repurchase of Common Stock	-2.72TCr	-278.3Cr	-1.6TCr	-9.88TCr	-7.9TCr
Common & Preferred Stock Dividends Paid	-	-441.7Cr	-444.1Cr	-878.5Cr	-857.9Cr
Common & Preferred Stock Dividends Paid	-	-441.7Cr	-444.1Cr	-878.5Cr	-857.9Cr
Other Financing Activities, Total	-179.2Cr	-233.9Cr	-258.5Cr	-427.3Cr	-343.3Cr
Cash from Financing	-2.77TCr	-262.6Cr	-2.11TCr	-11TCr	-7.86TCr
Foreign Exchange Rate Adjustments	-36Cr	419.1Cr	972.4Cr	3.08TCr	935.6Cr
Net Change in Cash	4.83TCr	-106.6Cr	11TCr	4.41TCr	-13TCr
Supplemental Items
Cash Interest Paid	40Cr	41Cr	42Cr	58Cr	140.5Cr
Cash Income Tax Paid (Refund)	2.05TCr	1.79TCr	3.76TCr	3.96TCr	5.42TCr
Levered Free Cash Flow	8TCr	8.72TCr	4.41TCr	8.61TCr	6.67TCr
Unlevered Free Cash Flow	8.02TCr	8.74TCr	4.44TCr	8.65TCr	6.76TCr
Change In Net Working Capital	-895.5Cr	-609.9Cr	889.5Cr	-1.74TCr	1.79TCr
Net Debt Issued / Repaid	-185.2Cr	-14Cr	-209.4Cr	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	9.6	9.6	6.37	6.72	7.72
Return on Total Capital	10.82	11	7.37	7.78	9.04
Return On Equity %	18.93	8.21	14.44	11.67	8.01
Return on Common Equity	19.68	8.45	14.86	11.84	8.05
Margin Analysis
Gross Profit Margin %	76.03	76.45	73.72	70.1	67.42
SG&A Margin	26.66	27.95	29.89	30.99	28.06
EBITDA Margin %	45.38	44.39	37.44	32.75	33.26
EBITA Margin %	42.29	41.46	34.35	30.83	31.23
EBIT Margin %	42.29	41.46	34.35	30.83	31.23
Income From Continuing Operations Margin %	45.56	18.94	41.2	28.27	16.79
Net Income Margin %	46.54	19.19	41.86	28.37	16.68
Net Avail. For Common Margin %	46.54	19.19	41.86	28.37	16.68
Normalized Net Income Margin	34.62	24.19	31.49	27.24	23.87
Levered Free Cash Flow Margin	32.18	29.74	16.07	24.34	15.75
Unlevered Free Cash Flow Margin	32.28	29.82	16.17	24.44	15.96
Asset Turnover
Asset Turnover	0.36	0.37	0.3	0.35	0.4
Fixed Assets Turnover	9	9.11	7.88	8.69	8.57
Receivables Turnover (Average Receivables)	8.29	11.82	14.25	14.73	12.39
Short Term Liquidity
Current Ratio	13.44	9.98	11.13	7.72	7.71
Quick Ratio	13.11	9.43	10.36	7.24	7.1
Operating Cash Flow to Current Liabilities	2.55	2.37	1.99	1.57	1.44
Days Sales Outstanding (Average Receivables)	44.05	30.96	25.61	24.78	29.45
Average Days Payable Outstanding	46.55	48.85	50.66	41.51	41.06
Long Term Solvency
Total Debt/Equity	2.04	2.3	1.81	2.69	3.28
Total Debt / Total Capital	2	2.25	1.78	2.62	3.17
LT Debt/Equity	1.35	1.64	1.45	2.22	2.66
Long-Term Debt / Total Capital	1.32	1.61	1.43	2.16	2.57
Total Liabilities / Total Assets	12.23	16.44	14.26	16.81	17.44
EBIT / Interest Expense	262.1	340.32	227.2	185.48	93.76
EBITDA / Interest Expense	281.29	364.34	247.6	196.99	99.85
(EBITDA - Capex) / Interest Expense	277.73	357.78	243.78	192.23	97.44
Total Debt / EBITDA	0.11	0.13	0.15	0.2	0.21
Net Debt / EBITDA	-4.42	-3.91	-5.06	-4.74	-4.03
Total Debt / (EBITDA - Capex)	0.12	0.13	0.15	0.21	0.22
Net Debt / (EBITDA - Capex)	-4.47	-3.99	-5.14	-4.85	-4.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.04	17.9	-6.33	28.88	19.69
Gross Profit, 1 Yr. Growth %	-3.68	18.55	-9.68	22.53	15.12
EBITDA, 1 Yr. Growth %	-0.71	15.31	-21	12.73	21.55
EBITA, 1 Yr. Growth %	-1.91	15.6	-22.4	15.67	21.21
EBIT, 1 Yr. Growth %	-1.91	15.6	-22.4	15.67	21.21
Earnings From Cont. Operations, 1 Yr. Growth %	9.96	-51	103.76	-11.56	-28.91
Net Income, 1 Yr. Growth %	7.42	-51.39	104.35	-12.66	-29.63
Normalized Net Income, 1 Yr. Growth %